Ustekinumab induction and maintenance therapy in refractory Crohn's disease

MLA

Sandborn, Wj, et al. Ustekinumab Induction and Maintenance Therapy in Refractory Crohn’s Disease. Jan. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....61da68785d51749a18aadbbf4b6659fb&authtype=sso&custid=ns315887.

APA

Sandborn, W., Gasink, C., Gao, L., Blank, M., Johanns, J., Guzzo, C., Sands, B., Hanauer, S., Targan, S., Rutgeerts, P., Ghosh, S., de Villiers WJ, Panaccione, R., Greenberg, G., Schreiber, S., Lichtiger, S., Feagan, B., Haas, T., Kaser, A., … Yen, E. (2012). Ustekinumab induction and maintenance therapy in refractory Crohn’s disease.

Chicago

Sandborn, Wj, C Gasink, Ll Gao, Ma Blank, J Johanns, C Guzzo, Be Sands, et al. 2012. “Ustekinumab Induction and Maintenance Therapy in Refractory Crohn’s Disease,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....61da68785d51749a18aadbbf4b6659fb&authtype=sso&custid=ns315887.